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Abstract It is widely accepted that silver nanoparticles
(AgNPs) are toxic to biological systems. However, little is
known about their actions at molecular level and the
cytophysiological effects after AgNP removal. As nanoparti-
cles are suggested a promising tool to transport drugs to the
brain for use in neurological conditions, we used HT22mouse
hippocampal neuronal cells as a model to study AgNP-
mediated effects after their removal from the cell culture me-
dium. We selected a relatively low concentration of AgNPs,
5 μg/ml, treated the cells for 48 h, and evaluated AgNP-
induced cytophysiological effects after 96 h of AgNP remov-
al. AgNP removal did not result in cytotoxicity. In contrast,
AgNPs modulated HT22 cell cycle and proliferation and in-
duced oxidative stress and 53BP1 recruitment, which were
accompanied by elevated levels of p53 and p21. AgNP-
associated diminution in lamin B1 pools did not significantly
affect the structure of the nucleus. No disruption in F-actin
dynamics was observed upon AgNP treatment. Moreover,
we showed for the first time that AgNPs stimulated changes
in DNA methylation: the augmentation in 5-methylcytosine
(5-mC) and DNMT1, DNMT2, DNMT3a, and DNMT3b
levels were observed. The upregulation of DNMT2 may be
a part of cellular stress response to AgNP treatment. Taken
together, AgNP removal resulted in p53/p21-mediated inhibi-
tion of cell proliferation, oxidant-based DNA damage re-
sponse, and changes in DNA methylation patterns, which
suggests that more attention should be paid to the possible
outcomes in individuals exposed to nano-sized biomaterials.
Keywords Silver nanoparticles . HT22 cells . DNA
methylation . DNMTs . Oxidative stress
Introduction
Silver-nanoparticle-based materials with potent antimicrobial
activities and unique physico-chemical properties are widely
used in electronics, biosensing, clothing, food industry, paints,
sunscreens, cosmetics, and medical devices [1–3]. Due to nu-
merous applications of silver nanoparticles (AgNPs) in bio-
medical sciences, a comprehensive analysis of AgNP effects
both short- and long-term actions on biological systems is
needed.
It has been repeatedly reported that AgNPs induced toxic-
ity both in vitro and in vivo [4–7]. AgNPs affected a plethora
of normal and cancer cell lines and AgNP toxicity was accom-
panied by oxidative stress: increased production of reactive
oxygen species (ROS) and/or glutathione depletion and de-
creased activity of antioxidant enzymes, whichmay contribute
to decreased proliferation, genotoxic events, and/or apoptosis
[4, 5, 8–14]. Despite some controversies on the mechanisms
of action of AgNPs [14–16], AgNP toxicity is suggested to be
independent of the toxicity of silver ions [12]. AgNPs and
silver ions were also shown to trigger two different cellular
responses as estimated using quantitative proteomics [17].
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AgNPs may affect the global gene expression [18–20], but
the mechanisms underlying such regulation are largely un-
known. After treatment of human lungA549 and cervical HeLa
cancer cells with AgNPs, the expression profiles of more than
1000 genes were modulated, e.g., encoding metallothioneins,
heat shock proteins, and histone proteins [18, 19]. Moreover,
AgNP-mediated defective DNA repair, proliferation arrest, and
inflammatory response in IMR-90 human lung fibroblasts and
U251 glioblastoma cells may be a consequence of AgNP-
induced changes in the gene expression patterns, such as the
upregulation of DNA damage response genes (GADD45) and
the downregulation of cell cycle progression genes encoding
cyclin B and cyclin E, and involved in DNA damage repair
(XRCC1, XRCC3, FEN1, RAD51C, RPA1) [20]. AgNPs, when
used at non-cytotoxic concentrations (<0.5 μg/ml), may also
promote some adverse effects by affecting the expression of
genes associated with cell cycle progression and apoptosis in
human hepatoma cells (HepG2) [7]. Data on the mechanisms
of AgNP-mediated regulation of the gene expression and pro-
tein translation are limited [21]. More recently, AgNP-induced
MT1F (metallothionein 1 F) and TRIB3 (tribbles homolog 3)
expressions have been reported to be regulated by miR-219-5p
in Jurkat T cells [21], which suggest the involvement of an
epigenetic mechanism.
Little is known on prolonged effects of low, non-cytotoxic
doses of AgNPs in the brain tissue. AgNP-induced dopami-
nergic neurotoxicity has been revealed in PC-12 rat neuronal
cell line [22, 23]. AgNPs also caused a significant stress re-
sponse in the growing human embryonic neural precursor
cells (HNPCs) by simultaneously affecting cell proliferation
and apoptotic cell death [24]. AgNP-mediated calcium dys-
regulation and reactive oxygen species (ROS) formation–
based response have been observed in a mixed primary cell
model (neurons, astrocytes, and a minor proportion of oligo-
dendrocytes) [25]. AgNP-induced calcium imbalance, desta-
bilization of mitochondrial function, and ROS production
have also been reported in primary cultures of cerebellar gran-
ule cells [26]. More recently, sublethal concentrations of
AgNPs have been found to disrupt actin dynamics in cultured
adult neural stem cells [27]. However, data on the
cytophysiological effects after AgNP removal from biological
systems are lacking, especially AgNP-mediated effects on
neural cell epigenome.
HT22 cells are considered as a sensitive model for moni-
toring cellular responses to oxidative stress due to the lack of
ionotropic glutamate receptors [28] and are widely used to
study the mechanisms of neurotoxicity and to search for neu-
roprotective compounds [29–31]. In the present study, we
used HT22 mouse hippocampal neuronal cell line to evaluate
prolonged effects of low concentration of AgNPs (5 μg/ml);
especially, we were interested if cell proliferation, redox state,
DNA damage response, and methylation parameters may be
affected after AgNP removal.
Materials and Methods
Chemicals
Dihydroethidium and MitoSOX™ were purchased from Mo-
lecular Probes (Leiden, Netherlands) and phosphate-buffered
saline (PBS) was obtained from (Gibco, Invitrogen Corpora-
tion, Grand Island, NY, USA). All other reagents, if not men-
tioned otherwise, were purchased from Sigma (Poznan, Po-
land) and were of analytical grade.
Nanoparticle Size and Zeta Potential Measurements
Silver nanoparticles (AgNPs), <100-nm particle size
(TEM; 758329, Sigma, Poznan, Poland), were character-
ized. Both particle size and the zeta potential of AgNPs
dispersed in water were measured using ZetaSizer Nano
ZS (Mavern Instruments, Mavern, UK) equipped with a
633-nm laser. The AgNP concentration and pH were
adjusted to values characteristic for suspension of the
particles in culture medium used. The dispersion was
measured at 25 °C. The particle size distribution was
assessed in a dynamic light scattering (DLS) mode on
the base of a correlation function analysis for scattering
angle of 173° (non-invasive back-scatter technology).
The refraction index for silver material was assumed
equal to 0.135. Prior to measurements, the samples were
sonicated for 30 min. Five replicates were performed
per measurement. The zeta potential of AgNPs in the
medium (pH=7.2) was assessed on the basis of Laser
Doppler Velocimetry (LDV) taking into account their
electrophoretic mobility. The Smoluchowski approxima-
tion was chosen for zeta potential evaluation. Three
replicates were performed per measurement, each at
hundred runs.
Nanoparticle Agglomeration Analysis
Atomic force microscopy (AFM) was used to elucidate
the tendency of AgNPs to agglomerate in DMEM cul-
ture medium and the susceptibility of serum compo-
nents to agglomerate in the presence of AgNPs. The
appropriate suspensions were deposited on atomic flat
mica substrate (V1 grade, Ted Pella Inc., USA) and
allowed to dry under N2 stream. AFM height sensor
images were collected in Peak Force Tapping mode
using Bioscope Catalyst II atomic force microscope
equipped with Nanoscope V controller (Veeco, Santa
Barbara, CA, USA). AFM topography imaging was
performed in the air using Bruker silicon scanasyst-flu-
id + probes. Images were processed and analyzed for
nanoparticle height by means of Nanoscope Analysis
(v. 1.40 R3sr5, Bruker) software.
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Protein Corona Formation Analysis
The ability of the serum proteins to bindAgNPs was evaluated
using sodium dodecyl sulfate polyacrylamide gel electropho-
resis (SDS-PAGE) and Coomassie staining. Briefly, DMEM
medium containing 10 % FBS was incubated with 5 μg/ml
AgNPs at 37 °C for 48 h. AgNP-treated medium was then
centrifuged (15,000 rpm, 15 min, 4 °C), washed three times
with ice-cold PBS (15,000 rpm, 15min, 4 °C), and added with
25 μl of PBS and 25 μl of 2× Laemmli buffer. The samples
were then vigorously mixed, boiled at 95 °C for 5 min, and
centrifuged (15,000 rpm, 15 min). The supernatants were col-
lected and resolved on 10 % SDS-PAGE. The gel was stained
using 0.25 % Coomassie Brilliant Blue R-250 in 45 % meth-
anol and 10% acetic acid for 30min, washed twice with water
for 10 min, and de-stained using 45 % methanol and 10 %
acetic acid solution for 1 h.
Cell Culture
HT22 mouse hippocampal neuronal cell line was a generous
gift from Prof. Michal Wozniak and Dr. Magdalena Gorska
(Medical University of Gdansk, Gdansk, Poland). Cells
(3000 cells/cm2) were cultured at 37 °C in Dulbecco’s modi-
fied Eagle’s medium (DMEM) supplemented with 10 % fetal
calf serum (FCS) and antibiotic and antimycotic mix solution
(100 U/ml penicillin, 0.1 mg/ml streptomycin, and 0.25 μg/ml
amphotericin B) in a humidified atmosphere in the presence of
5 % CO2 until they reached confluence. Typically, cells were
passaged by trypsinization and maintained in DMEM. The
freshly prepared stock solution of AgNPs (10 mg/ml in sterile
PBS) was added to HT22 cells to obtain final concentrations
ranging from 1 to 20 μg/ml.
Cytotoxicity, Cell Proliferation, and Cell Cycle Analysis
After 48-h treatment with AgNPs (1–20 μg/ml), cytotoxic/
cytostatic potential was estimated using MTT assay [32], cell
proliferation was established using bromodeoxyuridine
(BrdU) incorporation assay [33], and DNA-content-based cell
cycle analysis was conducted using imaging cytometry [34].
A concentration reflecting IC50 value (MTT assay), 5 μg/ml,
was selected to study prolonged effects of AgNPs. Briefly,
HT22 cells were incubated with 5 μg/ml AgNPs for 48 h,
washed three times with PBS, and cultured in AgNP-free me-
dium for up to 144 h (96 h after AgNP removal). Every 48 h,
the cells were washed three times with PBS and the medium
was replaced by a fresh one. Cytotoxicity, cell cycle, and cell
proliferation (DNA synthesis) were then evaluated. Cytotox-
icity was assayed using acridine orange-ethidium bromide
staining [35]. HT22 cells were washed twice with PBS, and
a mixture of acridine orange (100 μg/ml in PBS) and ethidium
bromide (100 μg/ml in PBS) at a volume ratio of 1:1 was
added to the cells, which were then analyzed with an Olympus
BX61 fluorescence microscope equipped with a DP72 CCD
camera and Olympus CellF software. Live/dead cell analysis
was conducted according to the principle that acridine orange
stained live cells green, while ethidium bromide stained dead
cells red to orange. A total of 200 cells were counted.
For DNA-content-based cell cycle analysis [34], HT22 cells
were stained with Hoechst 33342 (2.5 μg/ml) and digital cell
images were captured with an In Cell Analyzer 2000 (GE
Healthcare, UK) equipped with a high-performance CCD cam-
era. DNA content of a total of 200 cells was analyzed using
ImageJ software and DNA Cell Cycle plug-in from MBF Col-
lection (http://imagej.net/plugins/mbf/mbf-plugins.zip).
For DNA synthesis, BrdU assay was used [33]. BrdU was
added to the medium (10 μM) for 24 h and was detected using
primary antibody against BrdU (Becton Dickinson, Poland).
A total of 200 cells were analyzed under a fluorescence mi-
croscope, and the % of BrdU positive cells was calculated.
Moreover, cells were counted using a Bürker chamber.
Silver Ion and Serum Effects
The effects of AgNO3 on cell viability were also evaluated.
HT22 cells were cultured with AgNO3 (1–20 μg/ml) for 48 h
and MTT assay was conducted. Moreover, to evaluate the
effect of silver ion release from AgNPs, DMEM medium
was pre-incubated with AgNPs (5μg/ml) for 48 h, centrifuged
(15,000 rpm, 15 min), and used as a cell culture medium.
HT22 cells were also cultured in a serum-free medium in the
presence of 5 μg/ml AgNPs to establish serum-associated ef-
fect on AgNP-mediated cell viability (MTT assay).
Morphology, F-actin, and Nucleus Labeling
Cell morphology was monitored using an Olympus BX71
inverted microscope equipped with a DP72 CCD camera
and a computer image analysis system CellB. Intracellular
localization of AgNPs after 48-h treatment and after AgNP
removal was evaluated using Nomarski microscopy. To ana-
lyze AgNP-mediated changes in nucleus, HT22 cells were
fixed [32] and DNA was visualized using Hoechst 33342
staining. F-actin was stained using Alexa Fluor® 488
Phalloidin (a high-affinity filamentous actin, F-actin, probe
conjugated to green fluorescent Alexa Fluor® 488 dye) ac-
cording to manufacturer’s instructions (Life Technologies).
Additionally, lamin B1 was immunodetected using lamin B1
antibody (1:100, Life Technologies) and secondary antibody
conjugated with Texas red (1:1000, Life Technologies). Dig-
ital cell images were captured with an Olympus BX61 fluo-
rescence microscope equipped with a DP72 CCD camera and
Olympus CellF software. To analyze nuclear lamin B1 con-
tent, ImageJ software http://rsbweb.nih.gov/ij/ was used. We
evaluated the integrated fluorescence density (red channel),
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which is the sum of all pixel values within the marked area of
each nucleus analyzed and equivalent to the product of area
and mean gray value. The integrated fluorescence density is
presented in relative fluorescence units (RFUs). A total of
2000 cells were analyzed.
Oxidative Stress Parameters
Intracellular reactive oxygen species (ROS) production and
superoxide production, both total and mitochondrial, were
measured using 2′,7′-dichlorodihydrofluorescein diacetate
(H2DCF-DA), dihydroethidium, andMitoSOX
TM, respective-
ly, as described elsewhere [32].
53BP1 Immunostaining
For 53BP1 immunostaining, interphase nuclei were used.
HT22 cells were fixed with 3.7 % formaldehyde containing
0.1 % Triton X-100 in PBS for 20 min and incubated with 1 %
bovine serum albumin (BSA) in phosphate-buffered saline
containing 0.25 % Triton X-100 (PBST) at room temperature
for 30min. After washing with PBST, the cells were incubated
with a rabbit polyclonal antibody against 53BP1 (Novus Bio-
logicals, Poland; diluted 1:200 in PBST–BSA (PBSTcontain-
ing 1%BSA)) overnight at 4 °C, and with a FITC-conjugated,
secondary polyclonal antibody against rabbit IgG (BD Biosci-
ences, Germany; diluted 1:200 in PBST-BSA) at room tem-
perature for 1 h. Nuclei were visualized with Hoechst 33342.
Digital cell images were captured with an In Cell Analyzer
2000 (GE Healthcare, UK) equipped with a high-performance
CCD camera. The cells with 0, 1–3, 4–9, and more than 10
53BP1 foci (48-h treatment with 1–20 μg/ml AgNPs) or cells
with 0, 1, 2, and 3 53BP1 foci (96 h after AgNP removal) were
scored (%).
Western Blotting
Whole cell protein extracts were prepared according to Mytych
et al. [32]. Polivinylidene difluoride (PVDF) membrane was
incubated with one of the primary antibodies: anti-p21
(1:100), anti-p53 (1:1000), anti-lamin B1 (1:1000), anti-
DNMT2 (1:500), and anti-β-actin (1:1000) (Abcam, Thermo
Scientific and Novus Biologicals) and secondary antibody con-
jugated with HRP (1:80,000; Sigma). The respective proteins
were detected using the ECL Plus system (GE Healthcare),
according to themanufacturer’s instructions. The data represent
the relative density normalized to β-actin [32].
RNA Status
RNA was isolated using RNeasy Mini Kit (Qiagen, USA).
RNA chip electrophoresis was performed with Experion™
Automated Electrophoresis System and Experion™ RNA
Std-Sens Analysis Kit (Biorad, Germany). Total RNA level
(pg) was calculated per cell and RNA integrity as a 28S/18S
rRNA ratio [33].
Methylation Parameters
The levels of 5-methylcytosine (5-mC), and DNA methyl-
transferases 1, 3a, and 3b (DNMT1, DNMT3a and DNMT3b)
were measured usingMethylFlashTMMethylated DNAQuan-
tification Kit, EpiQuikTM DNMT1 Assay Kit, EpiQuikTM
DNMT3a Assay Kit, and EpiQuikTM DNMT3b Assay Kit,
respectively, (Epigentek, Farmingdale, NY, USA) according
to the manufacturer’s instructions. The calculations were
made on the basis of the standard curves obtained for positive
control solutions and 5-mC content is presented as nanograms
of 5-mC, and DNMT1, DNMT3a, and DNMT3b levels as ng/
mg protein.
Statistical Analysis
The results represent the mean±SD from at least three inde-
pendent experiments. The obtained data conform the ANOVA
assumptions as evaluated using Shapiro–Wilk normality test
and Levene test for the equality of variances. Statistical sig-
nificance was assessed by one-way ANOVA using GraphPad
Prism 5, with Dunnett’s multiple comparison test.
Results
As AgNPs were commercially purchased, we initially ana-
lyzed the AgNP size, dispersion stability, tendency to agglom-
erate in the cell culture medium, and protein corona formation
(Fig. 1).
The hydrodynamic size distribution analysis of AgNPs at a
concentration of 5 μg/ml showed a mean value of size equal to
8.05±0.88 nm. The polydispersity index of the system was
0.66 and thus below critical value of 0.7, indicating suitability
of the samples for DLS-based analysis and mono-size particle
dispersion assay. Typical size distribution patterns by volume
(a) and number (b) are shown in Fig. 1 in Panel I. A prominent
peak at about 8.7 nm and very low, broad peak around value of
90 nm were observed (Fig. 1, Panel I, a). Volumetric fraction
of the particles above 20 nm, which may be considered as
AgNP agglomerates, was 3.2 %. However, the transformation
of these data into size distribution by number (Fig. 1, Panel I,
b) indicated that almost 100 % of particles in sample are of the
size around 7.54± 1.77 nm, while localization of the peak
corresponding to the fraction of potentially clustered particles
was shifted to 45.4±16.2 nm. This confirms that the particle
fraction, which may be considered as agglomerates, is rather
marginal. The dynamic light scattering (DLS) analysis
showed variability of AgNPs in size ranging from
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Panel I
Panel II 
Fig. 1 AgNP characterization. Panel I: Representative distribution
patterns of silver nanoparticle size by volume (a) and number (b). The
measurements were performed using dynamic light scattering (DLS)
method. The size value corresponds to a peak position. Black arrows
indicate low, broad peaks corresponding to agglomerated particles.
Panel II: Representative electrophoretic mobility (a) and zeta potential
(b) distributions of silver nanoparticles obtained for hundred runs. The
inset in a shows a high quality phase plot generated for this dispersion
system using Laser Doppler Velocimetry (LDV). The results are
presented as mean ± SD. Panel III: Representative atomic force
microscopy (AFM) imaging of DMEM medium with and without
serum and with and without AgNPs incubated for 48 h and deposited
on atomic flat mica surface. (a) AgNPs (5 μg/ml) suspended in a serum-
free DMEM. The particles were of size from a few to about 20 nm (the
height profile used for particle size measurements is given in the inset)
and did not agglomerate. (b) DMEMwith serum in the absence of AgNPs
and (c) DMEM with serum in the presence of AgNPs (5 μg/ml). The
globular complexes of approximately 10 nm in size were typically
observed, whereas the agglomerates of the size above 100 nm were
rarely observed. The presence of AgNPs did not substantially alter
the particle size distribution. Height sensor images were obtained in
the Peak Force mode. Arrows indicate nano-objects subjected to
height profile analysis. Panel IV: The ability of serum proteins to
bind to the surface of AgNPs to form coating (the protein corona)
estimated using SDS-PAGE. Mild serum protein enrichment on the
surface on AgNPs was observed. Lane M: protein marker, Lane 1:
DMEM medium with 10 % FBS, Lane 2: 10 % FBS in PBS, Lane 3:
DMEM medium with 10 % FBS incubated with AgNPs (5 μg/ml) for
48 h (see “Materials and Methods” section for more details)




1290 Mol Neurobiol (2017) 54:1285–1300
approximately 3 nm to approximately 15 nm. The zeta poten-
tial of the AgNP dispersion showed a negative value and was
equal to about −28 mV (Fig. 1, Panel II, b). This value is close
to a critical value of −30 mV predicting potential physical
stability of the suspension. Thus, this indicates a low tendency
of AgNPs to aggregation because of the occurrence of the
surface electrical charge high enough to prevent particle inter-
actions. These data are consistent with estimation of the AgNP
size in the same dispersion system, which suggest the pres-
ence of a very low fraction of agglomerated particles exceed-
ing size of 20 nm. Moreover, AgNPs were characterized using
atomic force microscopy (AFM; Fig. 1, Panel III). The parti-
cles were quite uniformly distributed and did not show a ten-
dency to agglomerate in the DMEM medium. The size of the
particles ranging from a few to 20 nmwas consistent with that
determined hydrodynamically using ZetaSizer for water sus-
pensions and with the size of AgNPs observed by atomic force
microscopy when suspended in water [36]. To elucidate
whether the presence of AgNPs in serum suspension substan-
tially favored the formation of protein agglomerates as a result
of short-term incubation (48 h), we compared the AFM im-
ages of the DMEM and serum suspensions with and without
AgNPs. In the suspension without serum, the nanostructures
exhibiting the size from 20 to a few tens of nanometers were
dominated (Fig. 1, Panel IIIa). The fraction of larger particles,
around a hundred and more, occurred at much lower frequen-
cy. Representative height profiles are included on the right of
the images (Fig. 1, Panel IIIa). Similar particle size distribu-
tion was observed after 48-h incubation without and with
5 μg/ml AgNPs (Fig. 1, Panel IIIb and c). Two groups of
particles could be distinguished and both fractions were rep-
resented by the particles of similar size compared to the
suspension without AgNPs. Therefore, there is no evidence
that short-term incubation with AgNPs in culture medium
considerably affected the tendency to agglomeration. The
ability of serum proteins to bind to the surface of AgNPs
was also evaluated (Fig. 1, Panel IV). Serum protein enrich-
ment was observed only when the total medium volume
used (15 ml) was concentrated and subjected to protein co-
rona analysis (Fig. 1, Panel IV) after 48-h treatment with
5 μg/ml AgNPs.
HT22 mouse hippocampal cells were then subjected to
AgNP treatment (1–20 μg/ml) for 48 h, and AgNP-mediated
cytotoxicity, changes in the cell cycle, and cell proliferation
were evaluated (Fig. 2).
AgNPs caused a decrease in the number of metabolically
active cells (MTT assay; Fig. 2a, left). The effect was
concentration-dependent and statistically significant
(p< 0.001; Fig. 2a). The IC50 value was estimated to be
5 μg/ml (Fig. 2a, left). The toxicity of AgNO3 was also con-
sidered (Fig. 2a, left). At lower concentrations (up to 5 μg/ml),
AgNO3 was found to be less toxic than AgNPs (Fig. 2a, left)
that may suggest that AgNP effect differs from AgNO3 effect
on HT22 cells. To further characterize the involvement of
silver ions in AgNP toxicity, DMEM culture medium (with
and without serum) was pretreated with AgNPs for 48 h to
allow for silver ion release to the culture medium, centrifuged,
and used as a “normal” culture medium. We were unable to
observe any significant differences between pretreatment and
control conditions (Fig. 2a, middle).
The involvement of serum was also assayed (Fig. 2a,
right). The toxicity of 5 μg/ml AgNPs was potentiated
in a serum-free medium (p< 0.001; Fig. 2a, right) that
may be a result of protein corona formation-mediated
effects on the uptake, fate, and toxicity of AgNPs [37,
38].
AgNPs also promoted changes in the cell cycle (Fig. 2b).
After AgNP treatment, cells preferentially stayed in the G2/M
phase of the cell cycle. The percentage of cells in the G2/M
phase of the cell cycle increased from 8% (control conditions)
to approximately 33 % (treatment with 10 μg/ml AgNPs)
(p<0.001), and the level of cells in the G0-G1 phase of the
cell cycle decreased from 67% (control conditions) to approx-
imately 44 % (treatment with 10 μg/ml AgNPs; p<0.01;
Fig. 2b). Moreover, the percentage of cells in the S phase of
the cell cycle slightly dropped from 25 % (control conditions)
to approximately 22 % (treatment with 10 μg/ml AgNPs;
Fig. 2b). However, the effect was not statistically significant.
AgNPs also affected cell proliferation (Fig. 2c). After 5 and
20 μg/ml AgNP treatment, 30 and 55 % of cells were unable
to incorporate BrdU into their DNA, respectively, compared
to control (p<0.001; Fig. 2c).
We then asked the question of whether AgNP effects may
be prolonged and may affect cytophysiology of HT22 cells
after AgNP removal. A concentration reflecting the IC50 value
(MTT assay), 5 μg/ml, was selected for further analyses.
HT22 cells were incubated with 5 μg/ml AgNPs for 48 h,
washed, and cultured in AgNP-free medium for up to 144 h
(96 h after AgNP removal), and morphology, AgNP localiza-
tion, cytotoxicity, cell cycle, and cell proliferation analyses
were conducted (Fig. 3).
First, HT22 cell morphology was compared after 48-h
treatment and AgNP removal (Fig. 3a). AgNP treatment af-
fected cell morphology (Fig. 3a). The cells formed clusters
and the number of nucleoli was increased (Fig. 3a), whereas
AgNP removal resulted in cell morphology more similar to
control conditions (Fig. 3a). Intracellular localization (uptake)
of AgNPs was confirmed using Nomarski microscopy
(Fig. 3b). After AgNP removal, AgNPs were also observed
in HT22 cells (Fig. 3b). After 5 μg/ml AgNP removal, the
number of cells was decreased compared to control
(p<0.001; Fig. 3c). However, when considering 48-h treat-
ment, the cell yield was slightly increased (Fig. 3c). After
5 μg/ml AgNP removal, cytotoxic effects were not observed
(Fig. 3d). In contrast, changes in the cell cycle and the inhibi-
tion of cell proliferation were noticed (Fig. 3e, f). The
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percentage of cells in the G2/M phase of the cell cycle in-
creased from 10 % (control conditions) to approximately
17% (after AgNP removal; Fig. 3e).Moreover, the percentage
of cells in the S phase of the cell cycle dropped from 24 %
(control conditions) to approximately 20 % (after AgNP re-
moval; Fig. 3e). However, the effects were not statistically
significant. After 5 μg/ml AgNP removal, 20 % of cells were
unable to incorporate BrdU into their DNA compared to con-
trol (p<0.001; Fig. 3f).
As AgNPs may still modulate HT22 cell cycle and
proliferation after their removal, we decided to evaluate
if AgNP removal may also affect intracellular redox
homeostasis, 53BP1 recruitment, and the levels of p53,
p21, and lamin B1, and affect methylation parameters
and RNA status.
The removal of 5 μg/ml AgNPs was accompanied by ox-
idative stress (Fig. 4).
A 1.6-, 2.5-, and 1.6-fold increase in intracellular ROS,
total superoxide, and mitochondrial superoxide production
was observed, respectively, compared to control (p< 0.01
and p<0.001; Fig. 4).
Fig. 2 AgNP-induced cell viability (a), changes in the cell cycle (b), and
cell proliferation (c). HT22 cells were treated with AgNPs (1–20 μg/ml)
for 48 h. aMTTassay. Metabolic activity at standard growth conditions is
considered as 100 %. The bars indicate the SD, n = 5, ***p < 0.001
compared to control (ANOVA and Dunnett’s a posteriori test). HT22
cells were also treated with AgNO3 (1–20 μg/ml) for 48 h for
comparison (left). ###p < 0.001 compared to control (ANOVA and
Dunnett’s a posteriori test). The effect of silver ion release from AgNPs
was also evaluated (middle). DMEM medium was pre-incubated with
5 μg/ml AgNPs for 48 h and supernatant was used as a “normal”
culture medium; con, culture in DMEM with and without serum;
AgNP-pretreated, culture in AgNP-pretreated DMEM with and without
serum. The effect of serum on AgNP-mediated cell viability (right).
HT22 cells were incubated with 5 μg/ml AgNPs in the presence or the
absence of serum in DMEMmedium for 48 h. ***p< 0.001 compared to
control culture in complete medium, ###p< 0.001 compared to control
culture in a serum-free medium, ^^^p < 0.001 compared to 5 μg/ml
AgNP treatment in complete medium (ANOVA and Dunnett’s a
posteriori test). b Cell cycle analysis using imaging cytometry (In Cell
Analyzer 2000, GE Healthcare, UK) and ImageJ software. The bars
indicate the SD, n= 200, ***p< 0.001, **p< 0.01, compared to control
(ANOVA and Dunnett’s a posteriori test). c Cell proliferation was
estimated as the ability of cells to synthesize DNA: BrdU incorporation
assay. Cell proliferation at standard growth conditions is considered as
100 %. The bars indicate the SD, n= 200, ***p< 0.001 compared to
control (ANOVA and Dunnett’s a posteriori test)
Fig. 3 Impact of 5 μg/ml AgNP treatment and removal on cell
morphology (a), cellular localization of AgNPs (b), cell number (c),
cytotoxicity (d), cell cycle (e), and cell proliferation (f). HT22 cells
were treated with 5 μg/ml AgNPs for 48 h, AgNPs were then removed
and cells were cultured for another 96 h (a total culture time was 144 h). a
Cells were inspected using inverted microscope. b AgNPs were
visualized using differential interference contrast (DIC) microscopy and
DNA was stained using Hoechst staining (blue). c Cell number was
assessed using a Bürker chamber. The bars indicate the SD, n = 3,
***p< 0.001 compared to control (ANOVA and Dunnett’s a posteriori
test). d Cell viability was assessed using acridine orange-ethidium
bromide staining. e DNA-content-based cell cycle analysis using
imaging cytometry (In Cell Analyzer 2000, GE Healthcare, UK) and
ImageJ software. The bars indicate the SD, n = 200. f Cell proliferation
was estimated as the ability of cells to synthesize DNA: BrdU
incorporation assay. Cell proliferation at standard growth conditions is
considered as 100 %. The bars indicate the SD, n= 200, ***p< 0.001
compared to control (ANOVA and Dunnett’s a posteriori test) (color
figure online)
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We also investigated AgNP-mediated formation of p53
binding protein (53BP1) foci, which are considered to be ac-
cumulated at site of double-strand breaks (DSBs) being a part
of DNA repair process. The recruitment of 53BP1 was much
more accented after 48-h treatment with AgNPs (1–20 μg/ml)
than after removal of 5 μg/ml AgNPs (Fig. 5).
After 10 and 20 μg/ml AgNP treatment, the level of 53BP1
foci-positive cells were 30 and 50 %, respectively, compared
to 15% level of control (Fig. 5a). However, the recruitment of
53BP1 after removal of 5 μg/ml AgNPs was also observed
(Fig. 5b). The level of 53BP1 foci-positive cells increased
threefold compared to untreated control (Fig. 5b).
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After AgNP treatment, the levels of p53 and p21 were
elevated (Fig. 6a), which may contribute to AgNP-mediated
antiproliferative activity (Fig. 2).
Moreover, the levels of p53 and p21 remained high
after AgNP removal (Fig. 6a).
AgNPs also caused a diminution in lamin B1 pools
(Fig. 6a, b) that was not accompanied by changes in the nu-
cleus structure or F-actin cytoskeleton (Fig. 6b).
Finally, AgNPs stimulated methylation changes (Figs. 6
and 7). The effects were observed both after 48-h treatment
with AgNPs and after AgNP removal (Figs. 6 and 7).
AgNPs can be considered as a DNA hypermethylating
agent in HT22 cells, because AgNPs induced an increase
in the levels of 5-methylcytosine (5-mC), and DNA
methyltransferases 1, 3a, and 3b (DNMT1, DNMT3a,
and DNMT3b; Fig. 7a–d). After AgNP removal, the con-
tent of 5-mC was increased approximately 50 % com-
pared to control (p< 0.001; Fig. 7a). After AgNP remov-
al, an increase in DNMT1, DNMT3a, and DNMT3b
levels was less impressive compared to increased 5-mC
levels, but these effects were statistically significant
(p< 0.01 and p< 0.05; Fig. 7b–d).
Surprisingly, after AgNP removal, the level of
DNMT2, a methyltransferase suggested to be involved
in cellular stress responses, was elevated approximately
50 % compared to control (Fig. 6a). As DNMT2 may
have a protective role against RNA degradation [32], we
evaluated RNA status after AgNP treatment and AgNP
removal (Fig. 7e). The ratio of 28S/18S rRNA was un-
affected (values between 1.8 and 2.0) that may provide
evidence that RNA integrity (quality) was not compro-
mised upon AgNP stimulation (data not shown). AgNP
treatment did not result in changes in RNA pools, but
after AgNP removal, RNA synthesis was diminished
(Fig. 7e) that may reflect decreased transcriptional ac-
tivity of AgNP-treated cells as a result of increased
levels of DNMTs and subsequent global DNA hyperme-
thylation (Fig. 7a-d).
Discussion
AgNP-mediated response in HT22 hippocampal neuronal
cells was investigated; especially, attention was paid on low
concentration (5 μg/ml) and prolonged effects of AgNPs. We
showed for the first time that AgNP-induced effects retained
after AgNP removal from the cell culture medium. AgNPs
affected cell cycle, proliferation, redox homeostasis, response
to DNA damage, and the levels of p53, p21, and lamin B1,
Fig. 4 AgNP-induced oxidative stress. HT22 cells were treated with
5 μg/ml AgNPs for 48 h, AgNPs were then removed, and cells were
cultured for another 96 h (a total culture time was 144 h). Total reactive
oxygen species (ROS) production, intracellular superoxide production
both tota l and mitochondr ia l were measured with 2 ′ ,7 ′ -
dichlorodihydrofluorescein diacetate (H2DCF-DA), dihydroethidium,
and MitoSOXTM, respectively. Fluorescence intensity was monitored in
a Tecan Infinite® M200 fluorescence mode microplate reader. The bars
indicate the SD, n = 5, ***p < 0.001, **p < 0.01 compared to control
(ANOVA and Dunnett’s a posteriori test)
Fig. 5 AgNP-mediated 53BP1 recruitment. HT22 cells were treated with
AgNPs (1–20μg/ml) for 48 h (a) or HT22 cells were treated with 5μg/ml
AgNPs for 48 h and AgNPs were then removed and cells were cultured
for another 96 h (a total culture time was 144 h) (b). 53BP1 foci were
revealed using 53BP1 immunostaining. Cells with 0, 1–3, 4–9, and more
than 10 53BP1 foci (a) or cells with 0, 1, 2 and 3 53BP1 foci (b) were
scored (%)
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and promoted methylation changes that affected RNA
synthesis.
AgNP toxicity is well documented [4–7]. It has been pos-
tulated and rebutted that AgNP toxicity and related biological
effects may be due to silver ion toxicity [12, 14–17, 21]. In the
present study, the effect of silver ion release from AgNPs was
ruled out as there were no effects of AgNP-pretreated medium
supernatant on HT22 cells. We found that AgNP toxicity may
be affected by the presence of serum in the cell culture medi-
um, namely, in a serum-free medium AgNP toxicity may be
potentiated. Perhaps, AgNP toxicity may be modulated by the
formation of a protein corona (PC) on its surface (this study).
The fractions of enriched serum proteins were observed when
cell culture mediumwas concentrated and subjected to protein
corona analysis. Indeed, addition of the PC decreased uptake
of AgNPs by rat lung epithelial and rat aortic endothelial cells
and affected cellular toxicity via scavenger receptors [39].
Additionally, nanoparticle agglomeration in the cell culture
medium may affect its toxic activities [40–43]. However, we
did not observe AgNP tendency to agglomerate in the cell
culture medium using AFM imaging.
Themechanisms of AgNP toxicity involve oxidative stress,
DNA damage, and apoptosis that have been shown in numer-
ous human cell lines in vitro [1, 4, 5, 8–14]. AgNP-mediated
neurotoxicity has also been considered [22–26], especially
that nanoparticles may not only cause adverse effects in pri-
mary organs directly exposed but also in secondary organs,
such as the central nervous system (CNS).
AgNPs affected intracellular redox homeostasis by increas-
ing reactive oxygen species (ROS) production, lipid peroxi-
dation, and protein carbonylation, and/or decreasing the levels
of reduced glutathione and the activity of antioxidant enzymes
(e.g., superoxide dismutase and catalase) [4, 5, 8–14]. AgNP-
mediated oxidative stress and calcium dysregulation have also
been reported in neuronal cells that may promote apoptotic
cell death and/or neurodegeneration [22, 23, 26]. AgNP-
induced apoptosis involved mitochondrial pathway as AgNP
treatment resulted in cytochrome c release into the cytoplasm
and translocation of Bax to mitochondria in NIH3T3 fibro-
blast cells and human Chang liver cells [10, 13]. Moreover,
AgNPs may promote alterations in the mitochondrial mem-
brane potential (MMP) leading to abnormalities in
Fig. 6 AgNP-associated levels of p21, p53, lamin B1, and DNMT2.
HT22 cells were treated with 5 μg/ml AgNPs for 48 h or HT22 cells
were treated with 5 μg/ml AgNPs for 48 h and AgNPs were then
removed and cells were cultured for another 96 h (a total culture time
was 144 h). aWestern blot analysis of p21, p53, lamin B1, DNMT2, and
β-actin levels. Three blots representing three independent experiments
are shown. The bars indicate the SD, n = 3, **p < 0.01, *p < 0.05
compared to 48 h control (ANOVA and Dunnett’s a posteriori test). The
data represent the relative density normalized to β-actin. b
Immunofluorescence-based analysis of lamin B1 level (red). DNA was
stained using Hoechst 33342 staining (blue). F-actin was labeled using
Alexa Fluor® 488 Phalloidin staining (green). Lamin B1 nuclear signals
are presented as relative fluorescence units (RFUs). The bars indicate the
SD, n = 2000, ***p < 0.001 compared to 48 h control (ANOVA and
Dunnett’s a posteriori test) (color figure online)
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Fig. 7 AgNP-induced changes in methylation parameters and RNA
status. HT22 cells were treated with 5 μg/ml AgNPs for 48 h or HT22
cells were treated with 5 μg/ml AgNPs for 48 h and AgNPs were then
removed and cells were cultured for another 96 h (a total culture time was
144 h). a 5-Methylcytosine (5-mC) level (ng) (ELISA), b DNMT1 level
(ng/mg protein) (ELISA), cDNMT3a level (ng/mg protein) (ELISA), and
d DNMT3b level (ng/mg protein) (ELISA). The bars indicate the SD,
n = 3, ***p < 0.001, **p < 0.01, *p < 0.05 compared to 48 h control
(ANOVA and Dunnett’s a posteriori test). e RNA chip electrophoresis.
RNA molecular weight marker is also shown. Total RNA (pg) is
calculated per cell. The bars indicate the SD, n = 3
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physiological functions of mitochondria, which are common
during stress-induced apoptotic cell death [11, 13]. AgNP-
induced oxidative stress may also stimulate genotoxic events.
Indeed, AgNP treatment resulted in DNA adducts, DNA
breaks, oxidative DNA damage (increased 8-oxoguanine lev-
el), and micronuclei production [4, 13, 44–47]. AgNPs also
decreased 8-oxoguanine DNA glycosylase 1 (OGG1, DNA
repair enzyme that recognizes and excises 8-oxoguanine)
mRNA and protein expression, resulting in decreased OGG1
activity [44]. Thus, decreased OGG1 activity in AgNP-treated
cells led to increased 8-oxoguanine levels [44]. Surprisingly,
HT22 cells manifested DNA damage response (53BP1 re-
cruitment) even after AgNP removal from the cell culture
medium, which suggest that AgNPs may also promote
genotoxic effects (e.g., DNA double strand breaks) in these
cells. Under DNA double-strand break (DSB)-promoting con-
ditions, a complex cellular response is activated, which en-
ables to promote DNA repair and maintain genome integrity
[48], and 53BP1, p53 binding protein, is recruited to sites of
DNA damage due to methylation-state-specific recognition of
histone H4-K20 by 53BP1 [49]. Perhaps elevated levels of
p53 and p21 are a part of HT22 cell response to DNA damage
promoting conditions (AgNP treatment) and may account for
observed antiproliferative activity of AgNPs in these cells to
allow time for DNA repair.
AgNPs also decreased the levels of lamin B1, but this did
not significantly affect the structure of nucleus of a HT22 cell.
We have previously shown that diamond, silica, and silver
nanoparticles may promote a diminution in lamin B1 pools
in different cell lines both normal and cancer cells that is a part
of telomere-focused adaptive response [36]. More recently,
the effects of cobalt chrome (CoCr) nanoparticles on nuclear
morphology in human fibroblasts were studied [50]. Nano-
CoCr treatment resulted in oxidative-stress-mediated loss of
mature lamin B1 [50]. Mitochondrial ROS were implicated in
damage to lamin B1, increased incidence of micronuclei, and
misshapen nuclei [50]. Downregulation of lamin B1 may also
modulate the expression of antioxidant proteins and subse-
quent gene expression either through p53 or Oct-1 [51, 52].
Moreover, nuclear lamins as a ROS sink were suggested to be
mediators of oxidative stress [53].
As actin cytoskeleton may be disrupted by the action of
sublethal concentrations of AgNPs (0.1–1 μg/ml) in cultured
adult neural stem cells [27], we decided to evaluate if
5 μg/ml AgNP treatment and then AgNP removal may mod-
ulate actin cytoskeleton dynamics in HT22 cells. F-actin
cytoskeleton was unaffected upon AgNP stimulation (this
study). At higher concentration used (up to 50 μg/ml),
AgNPs disrupted filamentous actin, β-tubulin, and synaptic
machinery in cultured cortical neurons [54]. The authors
also concluded that associated disruption in neurogenesis
may contribute to documented deficits in brain function fol-
lowing AgNP exposure [27, 54].
Epigenetics, heritable modifications that alter gene expres-
sion levels without resulting from direct changes in the prima-
ry DNA sequence, is implicated in both physiological and
pathophysiological processes, such as development, cell pro-
liferation and differentiation, genetic imprinting, X chromo-
some inactivation, maintenance of chromatin structure, tumor
progression, cellular senescence, and organism aging [55–59].
In mammals, the main epigenetic mechanisms for gene regu-
lation are DNA methylation, histone tail modifications (acet-
ylation, phosphorylation, methylation), and microRNA
(miRNA)-mediated mechanisms [60, 61]. Gene silencing is
a result of DNA hypermethylation, whereas DNA hypome-
thylation activates transcription. DNA methyltransferases
(DNMTs) catalyze the transfer of a methyl group from S-
adenosylmethionine (SAM) to cytosine within CpG se-
quences to form 5-methylcytosine (5-mC) [62]. It is widely
accepted that DNMT1 is involved in the maintenance of DNA
methylation patterns during development and cell division,
whereas DNMT3a and DNMT3b are the de novo methyl-
transferases [63, 64]. The role of DNMT2 is more enigmatic,
but it may participate in the methylation of transfer RNA
molecules [65]. We showed that AgNPs may affect HT22 cell
epigenome by increasing the levels of 5-mC, DNMT1,
DNMT3a , and DNMT3b and ac t i ng as a DNA
hypermethylating agent. Data on epigenetic properties of
engineered nanomaterials, especially DNA-methylation-
based effects, are limited [66], and published results on
AgNP-mediated changes in DNA methylation patterns are
unavailable. There are two papers on nano-SiO2-induced
changes in global and loci-specific DNA methylation [67,
68]. Nano-SiO2 promoted global DNA hypomethylation (a
decrease in 5-mC level), which was accompanied by de-
creased DNMT1 and DNMT3a mRNA and protein levels in
HaCaT cells [67]. Moreover, nano-SiO2 caused PARP-1
hypermethylation and PARP-1 mRNA repression affecting
DNA damage repair process in HaCaT cell line [68]. In con-
trast, AgNPs were found to be a modulator of microRNA
profiles in Jurkat T cells [21]. An integrated analysis of
mRNA and miRNA expression revealed that the expression
of hsa-miR-219-5p was negatively correlated with the expres-
sion of metallothionein 1 F (MT1F) and tribbles homolog 3
(TRIB3), and epigenetic mechanism was suggested to be in-
volved in the toxicity of AgNPs in Jurkat T cells [21].
AgNPs also induced DNMT2 protein expression, which
may be considered as a part of stress response. The role of
DNMT2 in both DNA methylation and RNA methylation has
been proposed [64, 69, 70]. DNA methyltransferase activity of
human DNMT2 andDrosophilaDnmt2 has been reported [71,
72]. Moreover, a highly specific tRNAAsp methyltransferase
activity of DNMT2 has been postulated and rebutted [65, 73].
Regardless of the mechanism involved, DNMT2 is implicated
in the protection against cellular stresses, especially oxidative
stress, in different biological systems [74–76]. More recently,
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DNMT2 was found to be upregulated in HeLa cells upon treat-
ment with nanodiamonds, which contributed to RNA stabiliza-
tion and conferred stress resistance after nanodiamond treat-
ment [32]. Both stimulations—nanodiamond [32] and AgNP
(this study) treatments—resulted in oxidative stress in HeLa
andHT22 cells, respectively, and response to imbalanced redox
homeostasis may involve DNMT2-based protective response
against RNA degradation. Indeed, after AgNP treatment, RNA
integrity was not compromised.
In conclusion, we showed for the first time that AgNPs
may modulate HT22 cell proliferation, DNA damage re-
sponse, and epigenome acting as a DNA hypermethylating
agent. Thus, AgNPs may promote epigenetic dysregulation,
which may have long-term effects on gene expression re-pro-
gramming. Moreover, AgNP-induced effects may also be
manifested at the epigenomic level. As human exposure to
nanomaterials is rapidly increasing, it seems worthwhile to
study in detail the subsequent physiological effects of
AgNP-mediated epigenetic changes in biological systems in-
cluding neuronal cells and tissue.
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